冠心病的中西医治疗现状与研究进展
Current Status and Research Progress of Traditional Chinese and Western Medicine Treatment for Coronary Heart Disease
DOI: 10.12677/tcm.2026.156330, PDF,   
作者: 孟光洋:黑龙江中医药大学研究生院,黑龙江 哈尔滨;金 娟*:黑龙江中医药大学附属第一医院心血管病一科,黑龙江 哈尔滨
关键词: 冠心病胸痹中西医治疗现状研究进展Coronary Heart Disease Chest Obstruction Integrated Traditional Chinese and Western Medicine Current Treatment Status Research Progress
摘要: 冠状动脉粥样硬化性心脏病(Coronary Artery Disease, CAD)是由于冠状动脉粥样硬化使管腔狭窄或阻塞,导致心肌缺血、缺氧或坏死而引起的心脏病。中医归属于“胸痹”、“心痛”的范畴,多见于中老年人、高血压患者、高血脂人群、长期吸烟酗酒者及肥胖久坐人群,近年来发病呈明显年轻化趋势。该病以冠状动脉粥样硬化导致血管狭窄、闭塞,进而引发心肌缺血、缺氧甚至坏死,临床表现以胸闷、胸痛、心悸、气短为主,严重者可诱发急性心梗、猝死。西医治疗以快速改善心肌供血、抗栓、降脂、介入及手术,起效迅速;中医常采用中药内服、针灸、穴位贴敷等方式,在改善冠心病的症状、提高远期预后方面优势显著。本文系统梳理冠心病中西医治疗现状,为临床此病的防治提供参考。
Abstract: Coronary Artery Disease (CAD) is a heart disease caused by myocardial ischemia, hypoxia, or necrosis due to the narrowing or obstruction of the coronary artery lumen caused by coronary atherosclerosis. In traditional Chinese medicine, it falls under the categories of “chest obstruction” and “heart pain,” and is more common in middle-aged and elderly people, hypertensive patients, individuals with high blood lipids, long-term smokers and alcoholics, and obese sedentary individuals. In recent years, the disease has shown a noticeable trend of affecting younger people. This disease is characterized by coronary atherosclerosis leading to vascular stenosis and occlusion, which in turn causes myocardial ischemia, hypoxia, and even necrosis. The clinical manifestations mainly include chest tightness, chest pain, palpitations, and shortness of breath. In severe cases, it can induce acute myocardial infarction and sudden death. Western medicine treatment focuses on rapidly improving myocardial blood supply, antithrombotic therapy, lipid-lowering therapy, intervention, and surgery, which have rapid onset effects. Traditional Chinese medicine often employs methods such as oral administration of traditional Chinese medicine, acupuncture and moxibustion, and acupoint application, which have significant advantages in improving the symptoms of coronary heart disease and enhancing long-term prognosis. This article systematically reviews the current status of traditional Chinese and Western medicine treatments for coronary heart disease, providing a reference for the prevention and treatment of this disease in clinical practice.
文章引用:孟光洋, 金娟. 冠心病的中西医治疗现状与研究进展[J]. 中医学, 2026, 15(6): 189-194. https://doi.org/10.12677/tcm.2026.156330

参考文献

[1] 陈静锋, 焦贤飚, 朱君. 达格列净治疗稳定性冠心病合并心力衰竭的临床效果[J]. 临床合理用药, 2026, 19(8): 1-3+13.
[2] 任佳, 李霞, 朱君. 稳心颗粒联合美托洛尔治疗冠心病合并心律失常的临床效果[J]. 临床合理用药, 2026, 19(8): 32-35.
[3] 高鹏杰, 朱靖. 基于炎症因子治疗冠状动脉粥样硬化性心脏病的中医药研究进展[J]. 中医临床研究, 2025, 17(29): 76-81.
[4] 赵立坤, 葛长江, 吕树铮. 他汀类药物治疗冠心病抗炎机制的研究进展[J]. 中国现代医药杂志, 2009, 11(10): 123-125.
[5] 韩雅玲. 抗血小板药物在冠心病介入治疗中的应用[J]. 中国实用内科杂志, 2005, 25(1): 21-23.
[6] 仇昌智. 口服抗血小板药物在冠心病治疗中的应用[J]. 临床合理用药杂志, 2015, 27(4): 103-104.
[7] 王安才, 成蓓. 强化调脂治疗加强冠心病防治[J]. 皖南医学院学报, 2002, 21(1): 1-3.
[8] 熊厚军. 调脂药物在冠心病防治中的应用[J]. 中外健康文摘, 2011, 8(47): 247-248.
[9] 王阶, 赵涛, 李军, 等. 脑心通胶囊治疗冠心病的临床疗效与作用机制概述[J]. 中医杂志, 2020, 61(9): 814-817.
[10] 戴瑞鸿, 李勇. 冠心病心肌缺血的治疗性血管生成与中医药[J]. 中国中西医结合杂志, 2000(3): 163-164.
[11] 姚远, 梁峰, 沈珠军. 经皮冠状动脉介入治疗后冠心病心绞痛患者生存质量影响因素的分析[J]. 中国介入心脏病学杂志, 2015, 23(9): 508-511.
[12] 徐明, 陈绪军, 陈鑫, 等. 非体外循环冠状动脉旁路移植术加颈动脉内膜剥脱术治疗冠心病合并颈动脉狭窄[J]. 中国胸心血管外科临床杂志, 2011, 18(4): 301-304.
[13] 邵念方, 骆丰, 许荣廷. 冠心病中西医综合治疗[J]. 北京: 人民卫生出版社, 2004.
[14] 牛琳琳. 名老中医冠心病病因病机辨证分型初探[J]. 中国中医药咨讯, 2010, 2(32): 293, 291.
[15] 房玉涛, 王硕仁. 冠心病心绞痛中医药防治临床研究的现状调查[J]. 中国中西医结合杂志, 2003, 23(5): 338-340.
[16] 张华, 梁慕筠. 补阳还五汤治疗冠心病的临床研究及其作用机制探讨[J]. 中国中西医结合杂志, 1995(4): 213-215.
[17] 刘钰涵. 柴胡疏肝散治疗冠心病心绞痛(肝郁气滞证)临床疗效观察[D]: [硕士学位论文]. 沈阳: 辽宁中医药大学, 2014.
[18] 石月萍, 马骏. 加减枳实薤白桂枝汤治疗冠心病心绞痛[J]. 辽宁中医杂志, 2009, 36(6): 962-963.
[19] 刁利红, 严洁. 针灸治疗冠心病心肌缺血临床研究概况[J]. 湖南中医学院学报, 2004, 24(4): 59-61.
[20] 江武. 通痹散穴位贴敷治疗冠心病50例临床观察[J]. 光明中医, 2007(12): 80-81.